DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Putrescine is an investigational drug.
There have been 6 clinical trials for Putrescine. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Hypersensitivity, and Colorectal Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), University of Florida, and University Hospital, Bordeaux.
There are two US patents protecting this investigational drug and twenty-six international patents.
Recent Clinical Trials for Putrescine
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||BioGaia AB||Phase 4|
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||University of Zagreb||Phase 4|
|Feasibility Study on Stem Cells Sensitivity Assay||Associazione Oncologia Traslazionale||Phase 2|
Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Putrescine||Get Started for $10||Flame retarded thermoplastic moulding composition||DSM IP ASSETS B.V. (Heerlen, NL)||Get Started for $10|
|Putrescine||Get Started for $10||Process for preparing a diamine/dicarboxylic acid salt||DSM IP ASSETS B.V. (Heerlen, NL)||Get Started for $10|
|Putrescine||Get Started for $10||Method of producing metallic nano particle colloidal dispersions||ZEROVALENT NANOMETALS, INC. (Rochester, NY)||Get Started for $10|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Putrescine||China||CN105377946||2033-07-17||Get Started for $10|
|Putrescine||China||CN111393843||2033-07-17||Get Started for $10|
|Putrescine||European Patent Office||EP3022247||2033-07-17||Get Started for $10|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|